NYXH

Nyxoah SA · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website nyxoah.com
Employees(FY) 137
ISIN BE0974358906

Performance

+1.65%

-1.48%

-6.97%

-3.84%

+72.63%

YTD

+67.22%

Profile

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Advanced Technical Analysis

Technical Analysis of NYXH 2024-12-20

The stock indicators reflect a mixed sentiment, with the Moving Average Score at 36 indicating a bearish outlook, while the Oscillators Score of 53 suggests a neutral stance, and the Technical Score at 45 also leans towards neutrality. Overall, the combined scores imply a cautious market sentiment, with potential for volatility as the indicators...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of NYXH

Stock Rank

Recent News & Updates

2024-12-12 13:05
Nyxoah Announces Commercial Launch of Genio Innovative Therapy in England(Globenewswire)
2024-11-27 03:30
Information on the total number of voting rights and shares(Globenewswire)
2024-11-20 03:05
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference(Globenewswire)
2024-11-18 12:00
Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024(Globenewswire)
2024-11-18 03:30
Publication relating to transparency notifications(Globenewswire)
2024-11-06 03:05
Nyxoah Reports Third Quarter Financial and Operating Results(Yahoo Finance)
2024-11-04 03:45
Nyxoah Appoints John Landry as Chief Financial Officer(Globenewswire)
2024-10-25 04:30
Publication relating to transparency notifications(Globenewswire)
2024-10-22 04:30
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024(Globenewswire)
2024-10-15 04:30
Publication relating to transparency notifications(Globenewswire)
2024-10-09 04:35
Information on the total number of voting rights and shares(Globenewswire)
2024-10-09 04:30
Publication relating to transparency notifications(Globenewswire)
2024-10-08 05:49
Nyxoah Secures $27 Million to Boost U.S. Presence(Yahoo Finance)
2024-10-07 05:00
Nyxoah Raises $27 Million through its At-the-Market Offering(Globenewswire)
2024-09-27 04:30
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update(Globenewswire)
2024-09-26 14:05
Information on the total number of voting rights and shares(Globenewswire)
2024-09-26 14:00
Publication relating to transparency notifications(Globenewswire)
2024-09-05 04:30
Nyxoah to Participate in Upcoming Investor Conferences(Globenewswire)
2024-09-02 04:05
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device(Globenewswire)
2024-08-06 04:05
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results(Globenewswire)
2024-07-29 04:30
Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024(Globenewswire)
2024-07-14 14:00
Nyxoah Appoints Scott Holstine as Chief Commercial Officer(Globenewswire)
2024-07-02 18:30
Nyxoah Has Signed a 37.5 Million Loan Facility Agreement with the European Investment Bank(Globenewswire)
2024-06-30 14:00
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA(Globenewswire)
2024-06-28 04:30
Information on the total number of voting rights and shares(Globenewswire)
2024-06-03 04:30
Nyxoah to Participate in the Jefferies Global Healthcare Conference(Globenewswire)
2024-06-03 04:15
Information on the total number of voting rights and shares(Globenewswire)
2024-06-03 04:05
Publication relating to transparency notifications(Globenewswire)
2024-05-30 14:00
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares(Globenewswire)
2024-05-28 04:30
Information on the Total Number of Voting Rights and Shares(Globenewswire)

Page 1 of 6

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.